Translating Telephonic Diabetes Self-management Support to Primary Care Practice

July 24, 2020 updated by: Jeffrey Gonzalez, Albert Einstein College of Medicine

Translating Telephonic Diabetes Self-management Support to Primary Care Practice: The NYC Care Calls Trial

The goal of this study is to evaluate the implementation and effectiveness of an intervention to improve diabetes self-management, emotional distress and metabolic control among adults with type 2 diabetes receiving care in primary care practices throughout New York City. The program will be implemented by the New York City Department of Health, through their Primary Care Improvement Project.

Study Overview

Study Type

Interventional

Enrollment (Actual)

812

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 11101
        • New York City Department of Health and Mental Hygiene

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 21 years of age and older
  • Receiving treatment for diabetes at selected primary care practices throughout New York City
  • Most recent HbA1c ≥ 7.5% (max 3 months prior to randomization)
  • Ability to speak and read English or Spanish (or someone in the household who will read to them)
  • Access to a telephone
  • Willing to give informed consent to participate and accept random assignment.

Exclusion Criteria:

  • Stated intention to move out of the New York City area during the next year
  • Mental incapacity (e.g., confusion) evident on first telephone contact by Department of Health staff
  • Treatment provider deems that the patient is inappropriate for the trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Telephonic Diabetes Self-Management Support
This group receives all the Educational Print Materials received by the comparison condition plus telephone calls from a health educator to provide tailored diabetes self-management training and support. Participants with significant emotional distress at baseline also receive additional calls focused on distress management.
Active Comparator: Educational Print Materials
Participants randomized to this arm will receive print materials on diabetes, glycemic control, self-management, and distress/depression.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
HbA1c
Time Frame: Change from baseline at 12 months
Obtained from electronic medical record.
Change from baseline at 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diabetes Self-Management
Time Frame: Change from baseline at 12 months
Measured by self-report questionnaire
Change from baseline at 12 months
Medication Adherence
Time Frame: Change from baseline at 12 months
Measured by self-report questionnaire
Change from baseline at 12 months
Diabetes-related distress
Time Frame: Change from baseline at 12 months
Measured by self-report questionnaire
Change from baseline at 12 months
Depressive symptoms
Time Frame: Change from baseline at 12 months
Measured by self-report questionnaire
Change from baseline at 12 months
Blood pressure
Time Frame: Baseline and 12 months
Obtained from electronic medical record.
Baseline and 12 months
Cholesterol
Time Frame: Baseline and 12 months
Obtained from electronic medical record.
Baseline and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jeffrey S Gonzalez, PhD, Albert Einstein College Of Medicine
  • Principal Investigator: Winfred Y Wu, MD, MPH, New York City Department of Health and Mental Hygiene

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2014

Primary Completion (Actual)

September 20, 2019

Study Completion (Actual)

September 20, 2019

Study Registration Dates

First Submitted

May 8, 2014

First Submitted That Met QC Criteria

May 9, 2014

First Posted (Estimate)

May 14, 2014

Study Record Updates

Last Update Posted (Actual)

July 27, 2020

Last Update Submitted That Met QC Criteria

July 24, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2012-422
  • 1R18DK098742-01A1 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 2 Diabetes

Clinical Trials on Telephonic Diabetes Self-Management Support

3
Subscribe